Home Healthcare Market (2026 - 2035)

Global Home Healthcare Market Research Report: Size, Share, Trend Analysis By Product (Testing, Screening and Monitoring Products, Blood Glucose Monitors, Blood Pressure Monitors, Pulse Oximeters, Peak Flow Meters, Heart Rate Monitors, Fetal Monitoring Devices, HIV Test Kits, Home Sleep Testing Devices, Others), By Service (Skilled Nursing Services, Rehabilitation Therapy Services, Hospice and Palliative Care Services, Unskilled Care Services, Respiratory Therapy Services, Infusion Therapy Services, Others), By Indication (Cardiovascular Disorders and Hypertension, Diabetes, Respiratory Diseases, Pregnancy, Mobility Disorders, Hearing Disorders, Cancer, Wound Care, Other), And By Region – Market Forecast Till 2035
ID: MRFR/MED/1498-CR
85 Pages
Satyendra Maurya, Rahul Gotadki
Last Updated: June 25, 2026
Home Healthcare Market

Market Size

Forecast Period2026-2035
CAGR (2026-2035)7.65%
2025 Market SizeUSD 355.00 Billion
2035 Market SizeUSD 742.70 Billion

Key Players

Koninklijke Philips N.V.
Baxter International Inc.
Abbott Laboratories
GE HealthCare Technologies
ResMed Inc.
Amedisys Inc.
Trends
  • Aging Population and Chronic Disease Burden
  • Value-Based Reimbursement Expansion
  • Hospital-at-Home Program Proliferation
Opportunities
  • AI-Powered Predictive Care Models
  • Emerging-Market Insurance Expansion
  • Platform-Based Care Coordination
Request Free Sample

Home Healthcare Market Summary

The Global Home Healthcare Market size was valued at USD 355.00 Billion in 2025, and the market is projected to grow from USD 382.20 Billion in 2026 to USD 742.70 Billion by 2035, registering a CAGR of 7.65% during the forecast period 2026–2035. This trajectory is anchored by aging demographics across OECD nations and a decisive policy shift toward value-based reimbursement that rewards care delivered outside hospital walls. The U.S. Centers for Medicare & Medicaid Services broadened its Acute Hospital Care at Home waiver program in 2024, enabling over 300 health systems to bill inpatient-equivalent rates for residential episodes — a direct fiscal catalyst that reshaped capital allocation across the Home Healthcare Market [2].

Technology transformation is rewriting the delivery model. Legacy paper-based scheduling and manual vitals logging are giving way to cloud-hosted agency platforms, edge-computing biosensors, and AI-driven clinical decision support. The global digital health investment pool channeled roughly USD 18.5 Billion into connected home-care technologies between 2022 and 2024, with remote patient monitoring devices and predictive analytics attracting the largest funding rounds [3]. Device miniaturization has cut the per-unit cost of continuous glucose monitors and portable ECG patches by an estimated 30% since 2021, widening access in cost-sensitive emerging economies [4].

North America retained a 39.20% revenue share in 2025, driven by deep Medicare fee-for-service penetration and a mature staffing infrastructure. Asia-Pacific is on track to be the fastest-growing geography at a 10.15% CAGR through 2035, fueled by rising geriatric populations in Japan, rapid insurance expansion in India, and government digitization mandates across ASEAN [5]. Europe held the second-largest share at 27.50%, supported by EU-funded integrated care programs. The Home Healthcare Market will increasingly be defined by the convergence of clinical-grade wearables, telehealth platforms, and payer-led care-coordination models through the remainder of the decade.

Key Report Takeaways

• By Healthcare Type

  • Equipment commanded the leading share of the Home Healthcare Market in 2025, anchoring 45.20% of total revenue through therapeutic and diagnostic device categories.
  • Software Platforms are forecast to deliver the fastest segment expansion, advancing at a 13.10% CAGR to 2035 as agencies migrate from on-premise scheduling tools to cloud-native suites.

• By Indication

  • Cardiovascular conditions accounted for 24.70% of the 2025 Home Healthcare Market revenue mix, reflecting high demand for portable cardiac monitors.
  • Diabetes care is projected to grow at an 11.70% CAGR through 2035, propelled by the global surge in continuous glucose monitoring adoption.

• By Region

  • North America dominated the Home Healthcare Market with a 39.20% share in 2025.
  • Asia-Pacific is poised for the fastest regional CAGR of 10.15% over the forecast window.

Market Size and Forecast (2021–2035)

Market Research Future derives size estimates through a triangulated approach combining top-down revenue analysis, bottom-up device and service shipment data, primary interviews with 120+ home health agency executives, and validated secondary databases from CMS, WHO, and regional payer authorities.

Home Healthcare Market Size and Forecast
Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Driver Impact Analysis

Driver ~% Impact on CAGR Geographic Relevance Impact Timeline
Aging population and chronic disease burden 25–30% Global Long-term (≥4 yr)
Value-based reimbursement expansion 18–22% North America, Europe Medium-term (2–4 yr)
Hospital-at-home program proliferation 12–16% North America Short-term (≤2 yr)
Connected-device ecosystem maturation 10–14% Global Medium-term (2–4 yr)
Caregiver workforce policy reform 8–10% North America, Europe Medium-term (2–4 yr)
Emerging-economy insurance expansion 6–9% Asia-Pacific, South America Long-term (≥4 yr)
AI and predictive analytics integration 5–8% North America, Europe Long-term (≥4 yr)

 

Aging Population and Chronic Disease Burden

The UN projects that adults aged 65 and older will constitute 16% of the global population by 2030, up from 10% in 2022, generating an incremental demand pool of roughly 400 million individuals likely to require some form of residential care support. This demographic wave directly inflates utilization of the Home Healthcare Market as health systems worldwide prioritize de-institutionalization to contain costs that currently average USD 2,800 per inpatient day in the United States, versus roughly USD 170 per home-visit day [2].

Value-Based Reimbursement Expansion

CMS's Patient-Driven Groupings Model, fully implemented in 2020, shifted home health agency compensation toward outcome metrics, prompting a 22% increase in home-based therapy utilization between 2021 and 2024 [2]. European payers are following suit — Germany's Digital Care Act mandated reimbursement for certified digital health applications starting in 2020, and by 2024, over 50 DiGA-listed apps included home monitoring functionalities [6].

Hospital-at-Home Program Proliferation

The CMS Acute Hospital Care at Home waiver, initially a pandemic-era measure, covered more than 310 participating health systems by mid-2024, collectively managing an estimated 95,000 acute episodes in residential settings annually [7]. The program's 30-day readmission rate of 6.3% compared favorably with the 14.4% national inpatient benchmark, providing the clinical evidence base that sustains political support for permanent legislative authorization of the Home Healthcare Market delivery model [7].

Connected-Device Ecosystem Maturation

Bluetooth Low Energy, 5G narrow-band IoT, and edge-computing architectures have reduced the average deployment cost of a multi-sensor home monitoring kit from USD 1,200 in 2020 to approximately USD 640 in 2025 [4]. This cost compression expands the addressable population for chronic disease home management programs, particularly across lower-middle-income countries where per-capita health expenditure remains below USD 500 [5].

Restraints Impact Analysis

Restraint impacts are directional estimates reflecting headwinds that moderate growth below its potential ceiling. They do not subtract linearly from the CAGR.

Restraint ~% Impact on CAGR Geographic Relevance Impact Timeline
Caregiver workforce shortages −12 to −16% North America, Europe Short-term (≤2 yr)
Reimbursement and coverage gaps −8 to −12% Asia-Pacific, South America Medium-term (2–4 yr)
Data privacy and interoperability barriers −5 to −8% Global Medium-term (2–4 yr)
Rural broadband infrastructure deficits −4 to −6% South America, MEA Long-term (≥4 yr)
Regulatory fragmentation for home-use devices −3 to −5% Global Long-term (≥4 yr)

 

Caregiver Workforce Shortages

The U.S. Bureau of Labor Statistics estimates that the nation will face a shortfall of roughly 450,000 home health aides by 2028, driven by high turnover rates that exceed 65% annually in many states [9]. Median hourly wages of USD 15.40 for home health aides make recruitment difficult against competing retail and logistics roles, constraining the Home Healthcare Market's ability to convert latent demand into delivered episodes.

Reimbursement and Coverage Gaps

In many Asia-Pacific and South American markets, public insurance programs either exclude home-based skilled care or cap reimbursement at levels that do not cover agency operating costs. India's Ayushman Bharat scheme, for example, allocated less than 3% of its benefit package to domiciliary services as of 2024, limiting the addressable Home Healthcare Market in a country of 1.4 billion people [10].

Data Privacy and Interoperability Barriers

Fragmented electronic health record standards across jurisdictions create friction when agencies attempt to share patient data with hospital-based care teams. The EU's EHDS regulation, still in implementation as of 2025, aims to standardize cross-border data exchange but introduces compliance costs estimated at EUR 1.2 Billion across the bloc's home health providers [11].

Home Healthcare Market Opportunities

AI-Powered Predictive Care Models

A study published in JAMDA in 2024 showed that machine-learning systems trained on longitudinal home-monitoring data can predict hospitalization risk 48–72 hours in advance with sensitivity rates greater than 82% [8]. Organizations leveraging these methods can move from reactive visit scheduling to proactive intervention, decreasing 30-day readmissions and bolstering their position in value-based contracts across the Home Healthcare Market.

 

Emerging-Market Insurance Expansion

India, Indonesia and Brazil are gradually extending public health coverage to include specialized care in the home. In 2024, home-visit physiotherapy was added to Indonesia’s JKN program coverage, creating a market segment for its 270 million beneficiaries [5]. As these initiatives grow, early-mover equipment distributors and staffing platforms that build local partnerships will be positioned to gain a large portion.

 

Platform-Based Care Coordination

High-margin growth vector: software-as-a-service platforms that integrate scheduling, invoicing, clinical documentation and remote patient monitoring into unified dashboards. The business model is validated by payer readiness to pay for platform subscriptions as a cost avoidance tool (one large U.S. Medicare Advantage plan documented USD 2,100 per-member-per-year savings using integrated home-care platforms in 2024) [14].

 

Data Monetization Through Real-World Evidence

Home health agencies generate de-identified datasets that contain longitudinal vitals, medication adherence and functional status records that are sought after by pharmaceutical and medical device corporations for real-world evidence studies. The global real-world evidence analytics industry surpassed USD 2.3 Billion in 2024. Home-sourced data commands a premium as it captures the patient behavior outside of the clinical settings [15].

 

Post-Surgical and Post-Acute Transition Programs

Bundled-payment models increasingly incentivize hospitals to discharge patients to lower-cost settings within 48 hours of procedures such as joint replacements and cardiac catheterizations. The Home Healthcare Market is well positioned to absorb this volume: post-acute home episodes cost roughly 40% less than skilled nursing facility stays while delivering comparable functional outcomes [7].

Home Healthcare Market Future Outlook

AI-Autonomous Home Clinical Operations

By 2030, generative-AI care-plan engines are expected to automate 35–40% of clinical documentation tasks currently performed by home health nurses, freeing an estimated 12 million labor hours annually in the U.S. alone [8]. These tools will evolve from documentation aids into real-time clinical copilots that synthesize wearable data, pharmacy records, and social determinants into adaptive visit protocols, reshaping the operating economics of the Home Healthcare Market.

Platform Economics and Payer Integration

The disaggregated agency model — in which thousands of small providers compete on local referral relationships — is consolidating around technology-enabled platforms that aggregate supply, standardize quality metrics, and negotiate directly with Medicare Advantage and commercial payers [14]. By 2032, Market Research Future projects that platform-affiliated agencies will manage over 45% of U.S. home health episodes, up from an estimated 18% in 2025.

Decentralized Clinical Trials and Home-Based Research

Pharmaceutical sponsors are increasingly embedding home health visits into decentralized trial protocols, reducing patient dropout by an estimated 25% compared with site-based designs [15]. This convergence between clinical research and the Home Healthcare Market creates a new revenue stream for agencies equipped with GCP-trained staff and validated digital endpoints.

Sustainability and Carbon Footprint Reduction

Delivering care at home reduces per-episode carbon emissions by an estimated 60% compared with inpatient stays when accounting for building energy, supply-chain logistics, and patient transportation [17]. As ESG reporting requirements tighten across U.S. and European health systems, carbon-efficiency metrics will become a procurement consideration that favors home-based care models.

Home Healthcare Market Segmentation

By Healthcare Type

Segment Key Metric Primary Demand Driver
Equipment (Therapeutic, Diagnostic & Monitoring) 45.20% share (2025) Portable device innovation, cost compression
Services (Skilled Nursing, Rehabilitation) USD 126.70 Billion (2025) Aging population, post-acute discharge volume
Software (Agency Administration, Clinical) 13.10% CAGR (2026–2035) Cloud migration, interoperability mandates

 

Equipment remains the revenue anchor of the Home Healthcare Market, driven by therapeutic devices such as insulin delivery systems, CPAP machines, and infusion pumps that patients use on a recurring basis. Diagnostic and monitoring hardware — including pulse oximeters, blood pressure monitors, and portable ECG patches — continues to see unit-cost declines that expand the addressable population.

Software Platforms represent the fastest-growing segment as agencies transition from legacy on-premise systems to cloud-native suites that integrate billing, scheduling, clinical documentation, and analytics. CMS's mandate for electronic visit verification accelerated this migration, and agencies that adopted unified platforms reported 15–20% administrative cost reductions within the first year of deployment [14].

By Indication

Segment Key Metric Primary Demand Driver
Cardiovascular 24.70% share (2025) High prevalence, cardiac rehab-at-home programs
Diabetes 11.70% CAGR (2026–2035) CGM adoption, insulin delivery innovation
Respiratory USD 59.60 Billion (2025) COPD management, home oxygen therapy
Neurological 9.30% CAGR (2026–2035) Stroke rehabilitation, neurodegenerative disease burden
Orthopedic USD 44.40 Billion (2025) Bundled-payment post-surgical discharge
Others 13.30% share (2025) Wound care, palliative care

 

Cardiovascular conditions lead the Home Healthcare Market indication mix because heart failure, hypertension, and post-cardiac-event monitoring generate recurring visit schedules and continuous device utilization. Diabetes is the fastest-growing indication segment: the global installed base of continuous glucose monitors surpassed 35 million units in 2024, and payer coverage expansions in Europe and Asia are accelerating adoption further [4].

Regional Market Share Analysis

Region Key Metric Primary Investment Themes
North America 39.20% share (2025) Hospital-at-home waivers, Medicare Advantage home benefits
Europe USD 97.60 Billion (2025) EU integrated care directives, DiGA ecosystem
Asia-Pacific 10.15% CAGR (2026–2035) Insurance expansion, geriatric population growth
South America USD 21.30 Billion (2025) SUS modernization, private payer expansion
Middle East & Africa 8.20% CAGR (2026–2035) Vision 2030 healthcare programs, urbanization
Total USD 355.00 Billion (2025) —

The Home Healthcare Market exhibits significant geographic variation driven by payer structures, demographic profiles, and digital infrastructure maturity.

 

North America

Country Key Metric Key Driver
US 78.50% of regional share CMS waiver programs, Medicare reimbursement depth
Canada 14.20% of regional share Provincial home-first policies
Mexico 7.30% of regional share Private insurance growth, IMSS pilot programs

 

The United States accounts for the vast majority of the North American Home Healthcare Market due to deep Medicare fee-for-service and Medicare Advantage penetration. Canada's home-first care strategies across provinces like Ontario and British Columbia are driving double-digit annual growth in publicly funded home visits, while Mexico's private payer segment is expanding as employers add domiciliary benefits to corporate health plans [2] [7].

Europe

Country Key Metric Key Driver
Germany 7.85% CAGR DiGA digital therapeutics mandate
UK USD 17.80 Billion (2025) NHS virtual ward programs
France 18.30% of regional share HAD (Hospitalisation à Domicile) framework
Italy 7.40% CAGR PNRR home-care investment
Spain 9.50% of regional share Ley de Dependencia expansion
Nordic Countries 8.10% CAGR Advanced digital health infrastructure
Russia USD 4.60 Billion (2025) Private clinic networks, urban concentration
Rest of Europe 15.70% of regional share Varied regulatory progress

 

European growth in the Home Healthcare Market is propelled by the EU's NextGenerationEU recovery fund, which earmarked over EUR 37 Billion for health digitization and primary-care strengthening across member states [6]. Italy's PNRR plan alone allocated EUR 7 Billion to territorial health reform, including 1,350 new community health houses designed to coordinate home-visit programs.

Asia-Pacific

Country Key Metric Key Driver
China USD 22.40 Billion (2025) Aging population, 14th Five-Year Plan health targets
India 11.60% CAGR Ayushman Bharat expansion, private home-care startups
Japan 28.20% of regional share Super-aged society, Kaigo Hoken long-term care insurance
South Korea 8.90% CAGR National Health Insurance coverage extensions
ASEAN USD 8.50 Billion (2025) UHC programs in Thailand, Indonesia
Rest of Asia-Pacific 7.80% CAGR Varied development stages

 

Asia-Pacific represents the fastest-growing region in the Home Healthcare Market, with Japan's super-aged demographic structure generating per-capita home-care expenditure that ranks among the world's highest [5]. India's venture-funded home-care platforms — several of which raised Series B and C rounds exceeding USD 50 Million in 2023–2024 — are building last-mile nursing and diagnostics networks across tier-2 and tier-3 cities.

South America

Country Key Metric Key Driver
Brazil 62.40% of regional share SUS integration, private hospital-at-home programs
Argentina 7.60% CAGR Obra social coverage modernization
Rest of South America USD 4.20 Billion (2025) Early-stage formalization

 

Brazil dominates the South American Home Healthcare Market through its Sistema Único de Saúde public health network, which has progressively integrated home-care modalities into primary-care budgets [10]. Private hospital groups such as Rede D'Or have launched branded hospital-at-home services in São Paulo and Rio de Janeiro, targeting post-surgical and chronic-care episodes.

Middle East & Africa

Country Key Metric Key Driver
Saudi Arabia 32.50% of regional share Vision 2030 healthcare diversification
UAE 9.10% CAGR DHA home-care licensing framework
South Africa USD 2.90 Billion (2025) Private medical aid schemes
Egypt 8.40% CAGR Population scale, rising NCD burden
Rest of MEA 30.20% of regional share Fragmented but growing private sector

 

Saudi Arabia's Vision 2030 health transformation program is a key catalyst for the Home Healthcare Market in the MEA region, with the Ministry of Health targeting a 30% increase in home-care service capacity by 2028 through public-private partnerships and digital health mandates [16].

Home Healthcare Market By Region, 2025-2035

Competitive Benchmarking

The Home Healthcare Market exhibits moderate concentration with an estimated top-five revenue share of 28–34% and a Herfindahl-Hirschman Index in the low-to-moderate range (approximately 550–750). The competitive field spans diversified medical device conglomerates, dedicated home health service providers, and venture-backed software entrants, creating a layered rivalry across equipment, staffing, and technology.

Company Est. Revenue Share Range Key Offerings Strategic Positioning
Koninklijke Philips N.V. ~5–8% Connected care devices, telehealth platforms Integrated device-software ecosystem
Baxter International Inc. ~4–7% Home infusion therapies, renal care Clinical depth in acute home therapies
Abbott Laboratories ~4–6% CGM systems, diagnostics Wearable sensor leadership
GE HealthCare Technologies ~3–5% Patient monitoring, imaging Hospital-to-home continuum technology
ResMed Inc. ~3–5% CPAP/BiPAP devices, SaaS platforms Sleep and respiratory home management
Amedisys Inc. ~3–5% Skilled nursing, hospice services Largest pure-play U.S. home health agency
BrightSpring Health Services ~2–4% Home and community health services Scale in pharmacy and behavioral health
Medline Industries ~2–4% Medical supplies, home-care kits Distribution and supply-chain breadth
LHC Group (UnitedHealth) ~2–4% Home nursing, personal care Payer-provider vertical integration
Encompass Health Corporation ~2–3% Home health, hospice Post-acute care network density

 

Recent News & Developments

 

 

 

  • CMS (November 1, 2024 ): Finalized the CY2025 Home Health Prospective Payment Rule, increasing aggregate payments by 1.7% and expanding telehealth-eligible visit types [7].

 

 

 

Home Healthcare Market Report Scope

Parameter Detail
Market Scope Home Healthcare Market covering equipment, services, and software globally
Study Period 2021–2035
CAGR (Forecast) 7.65% (2026–2035)
Base Year Market Size USD 355.00 Billion (2025)
Forecast Endpoint USD 742.70 Billion (2035)
Fastest Growing Segment Software Platforms (13.10% CAGR)
Companies Profiled 10 major players
Valuation Currency USD Billion

 

FAQs

What licensing requirements apply to home health agencies entering new U.S. states?

Each state imposes its own home health agency licensure, with certificate-of-need laws in roughly 15 states requiring proof of community demand before approval [2]. Agencies should budget 6–12 months and USD 50,000–150,000 per state for the full licensing cycle.

How do integrated delivery networks evaluate home health technology vendors?

Procurement committees prioritize EHR interoperability, HIPAA-compliant data exchange, and demonstrated 30-day readmission reductions [14]. Vendors that publish peer-reviewed outcomes data consistently outperform competitors in RFP scoring.

What role does private equity play in Home Healthcare Market consolidation?

PE firms completed over 85 home health platform acquisitions between 2021 and 2024, targeting agencies with USD 20–80 Million revenue for tuck-in roll-ups [3]. This capital inflow accelerates technology adoption but raises regulatory scrutiny around care quality.

How do reimbursement structures differ between Medicare fee-for-service and Medicare Advantage for home care?

Fee-for-service pays per 30-day episode under PDGM, while Medicare Advantage plans negotiate capitated or per-visit rates directly with agencies [7]. Advantage plans increasingly require telehealth integration as a contract prerequisite.

What cybersecurity frameworks should home health agencies adopt?

The NIST Cybersecurity Framework and HITRUST CSF are the most widely recognized standards for protecting patient data transmitted by home-based devices [11]. Agencies handling Medicare data face HIPAA audit exposure that makes certification a practical necessity.

How are home health staffing agencies adapting to wage inflation?

Leading staffing firms have introduced tiered compensation models linking pay to acuity, geography, and certification level [9]. Retention bonuses of USD 2,000–5,000 and tuition reimbursement programs are becoming standard recruitment tools.

What clinical outcome benchmarks distinguish high-performing home health providers?

CMS Star Ratings weight timely initiation of care, hospitalization rates, and functional improvement scores most heavily [7]. Top-quartile agencies achieve hospitalization rates below 12% and functional improvement scores above 70%.    
Author
Author
Author Profile
Satyendra Maurya LinkedIn
Research Analyst
An accomplished research analyst with high proficiency in market forecasting, data visualization, competitive benchmarking, and others. He holds a pronounced track record in research and consulting projects for sectors such as life sciences, medical devices, and healthcare IT. His capabilities in qualitative and quantitative analysis have resulted in positive client outcomes. Working on niche market trends, opportunities, sales, and forecasted value is part of his skill set.
Co-Author
Co-Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Get In Touch

Research Approach

 

Secondary Research

The secondary research process involved systematic analysis of regulatory filings, peer-reviewed clinical literature, medical device databases, and authoritative healthcare statistics. Key sources included the Centers for Medicare & Medicaid Services (CMS), US Department of Health and Human Services (HHS), Food and Drug Administration (FDA) Medical Device Databases, National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), Centers for Disease Control and Prevention (CDC) National Center for Health Statistics, European Medicines Agency (EMA), National Health Service (NHS) Digital, World Health Organization (WHO) Global Health Observatory, OECD Health Statistics, National Association for Home Care & Hospice (NAHC), Home Care Association of America (HCAOA), American Association for Respiratory Care (AARC), American Telemedicine Association (ATA), Healthcare Information and Management Systems Society (HIMSS), and national health ministry databases from key markets.

These resources made it easier to gather information on medical device approval records, chronic disease prevalence statistics, telehealth adoption metrics, skilled nursing utilization rates, reimbursement policy data, and demographic aging trends for a variety of home healthcare service categories, such as respiratory therapy, infusion therapy, skilled nursing, rehabilitation therapy, and hospice care.

 

Primary Research

In order to collect both qualitative and quantitative intelligence, supply-side and demand-side stakeholders were surveyed and interviewed in an organized manner during the main research process. CEOs, COOs, VPs of clinical services, regulatory affairs managers, and commercial leaders from home healthcare organizations, makers of durable medical equipment, suppliers of remote patient monitoring technologies, and developers of telehealth platforms were among the supply-side attendees. Demand-side participants included hospital-at-home program procurement directors, geriatric specialists, certified home health nurses, physical therapists, palliative care coordinators, insurance reimbursement managers, family caregiver representatives, and primary care physicians. Primary study established technology adoption timescales, validated service line segmentation, and collected data on patient choice shifts across testing/monitoring device and therapy service categories, workforce shortage impacts, and reimbursement dynamics.

Primary Respondent Breakdown:

By Designation: C-level Primaries (30%), Director Level (35%), Others (35%)

By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)

 

Market Size Estimation

Revenue triangulation and service volume analysis across device and service segments were used to determine the global market valuation. The approach included:

Identification of more than fifty important parties, including home health agencies, DME producers, and telehealth providers, throughout North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa

Product and service mapping for skilled nursing services, respiratory treatment, infusion therapy, hospice and palliative care, rehabilitation therapy, and testing/screening/monitoring equipment (blood glucose monitors, blood pressure monitors, pulse oximeters, and fetal monitoring devices).

Analysis of Medicare/Medicaid payment claim data and reported and estimated yearly revenues unique to home healthcare portfolios

coverage of manufacturers and service providers that will account for 72–78% of the worldwide market in 2024

Segment-specific valuations for telemedicine, remote patient monitoring, and traditional home nursing services were obtained by extrapolating using top-down (provider revenue validation) and bottom-up (procedure volume × reimbursement rates by country) approaches, cross-referencing them with government health expenditure databases and insurance claims data.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Customer Stories

Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.